
    
      The collection of data from patients with CHC and cholangiocarcinomas who are cancers with
      poor prognosis is a major challenge to improve patients'care (diagnosis, prognosis);
      facilitate the search for new therapeutic targets and the follow-up of clinical studies; and
      develop personalized treatments.
    
  